שליחה במסרון: COSTS AND BENEFITS OF METHADONE TREATMENT IN DATOS. PART I: DISCHARGED VERSUS CONTINUING PATIENTS. PART II: GENDER DIFFERENCES FOR DISCHARGED AND CONTINUING PATIENTS